Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Elutia Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −7 vs. Q2 2021
- Shares held
- 1.90M
- −152.8K (−7.5%) vs. Q2 2021
- Total value
- $13.2M
- −$6.49M (−32.9%) vs. Q2 2021
- New holders
- 1
- 8 more added
- Sold out
- 8
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELUT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $13.8M |
| Q1 2026 | 35 | $16.0M |
| Q4 2025 | 33 | $11.1M |
| Q3 2025 | 31 | $16.1M |
| Q2 2025 | 28 | $34.4M |
| Q1 2025 | 31 | $43.6M |
| Q4 2024 | 32 | $49.3M |
| Q3 2024 | 29 | $46.7M |
| Q2 2024 | 26 | $44.5M |
| Q1 2024 | 22 | $17.9M |
| Q4 2023 | 24 | $14.9M |
| Q3 2023 | 21 | $9.20M |
| Q2 2023 | 19 | $7.23M |
| Q1 2023 | 18 | $4.20M |
| Q4 2022 | 19 | $18.4M |
| Q3 2022 | 17 | $24.0M |
| Q2 2022 | 17 | $23.6M |
| Q1 2022 | 17 | $19.4M |
| Q4 2021 | 15 | $19.8M |
| Q3 2021 | 17 | $13.2M |
| Q2 2021 | 24 | $19.7M |
| Q1 2021 | 31 | $23.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Elutia Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Endurant Capital Management LP | 952,610 | $6.63M | 2.01% | +79,451+9.1% | Added |
| Brown Advisory Inc | 230,667 | $1.60M | 0.00% | −51,582−18.3% | Reduced |
| Perkins Capital Management Inc | 228,425 | $1.59M | 0.98% | +74,000+47.9% | Added |
| Platinum Investment Management Ltd | 195,809 | $1.36M | 0.04% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 126,720 | $896.0K | 0.09% | −48,930−27.9% | Reduced |
| Vanguard Group Inc | 55,570 | $386.0K | 0.00% | +309+0.6% | Added |
| Birchview Capital, LP | 50,000 | $348.0K | 0.24% | +20,000+66.7% | Added |
| Millennium Management LLC | 28,550 | $202.0K | 0.00% | +12,047+73.0% | Added |
| Man Group plc | 11,147 | $79.0K | 0.00% | +933+9.1% | Added |
| Morgan Stanley | 7,026 | $49.0K | 0.00% | +3,731+113.2% | Added |
| BlackRock Inc. | 6,523 | $45.0K | 0.00% | −8,757−57.3% | Reduced |
| UBS Group AG | 1,629 | $11.0K | 0.00% | −452−21.7% | Reduced |
| Nisa Investment Advisors, LLC | 1,300 | $9.00K | 0.00% | −10,500−89.0% | Reduced |
| Bank of America Corp | 641 | $4.00K | 0.00% | −435−40.4% | Reduced |
| US Bancorp | 625 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 181 | $1.00K | 0.00% | +181 | New |
| Wells Fargo & Company | 27 | $0 | 0.00% | +14+107.7% | Added |
| RTW Investments, LP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −83,253−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −2,871−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,687−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −33−100.0% | Sold out |